AstraZeneca (AZN)
Share price graph
Contact details
Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com
Company information
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.
Related news from City A.M.
Astrazeneca has hailed the success of its new Type 2 diabetes drugs, after a study of more than 300,000 people [...]
Shares in Neil Woodford-backed pharmaceuticals firm Circassia rocketed over 30 per cent this morning after [...]
Pharmaceuticals giant AstraZeneca has turned to an innovative startup helping patients, doctors and researchers [...]
AstraZeneca has struck a $320m (£256m) deal with TerSera Therapeutics to sell the commercial rights of its [...]
AstraZeneca shares slipped over one per cent after warning many of its patents will run out during 2017. [...]
AstraZeneca is forecast to report disappointing results this week as competition continues to drag on sales. [...]
London's top share index hit a fresh all-time high yesterday, setting a record for the longest winning streak [...]
2016's events made fools of most pundits, and looking back at my column exactly a year ago, I fared little better. [...]
Pharmaceutical giant AstraZeneca has bagged $550m (£446m) in an initial payment from the sale of its late-stage [...]
AstraZeneca's biological arm MedImmune and US life sciences group Abpro have joined forces on a new research [...]
FTSE 100 pharma firm Hikma has cut its full-year sales guidance for its US generics business to roughly $600m, [...]
AstraZeneca posted weak quarterly profits this morning, but big pharma companies are expected to benefit from [...]
Pharmaceutical stocks – one of the few sectors that was thought to be privately if not publicly hoping for a [...]
Drug giant AstraZeneca, which reports its third quarter results on Thursday, is expected to remain under pressure [...]
Pharmaceuticals bosses are set to meet with ministers next month in a bid to press their case for government support [...]
Content tagged with "AstraZeneca"